{"entity":{"type":"insider","cik":"0001543031","url":"/insider/0001543031","json_url":"/insider/0001543031.json","name":"Quimi Daphne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":22,"first":"2014-10-01","last":"2024-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Quimi Daphne","source":"filing","n_filings":22,"first_seen":"2014-10-01","last_seen":"2024-09-16"}],"transactions":[{"id":2528196,"accession":"0001062993-24-016641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-016641","line_url":"/filing/0001062993-24-016641#line-1","is_derivative":false,"issuer_cik":"0001543031","issuer_name":"Century Therapeutics, Inc.","issuer_ticker":"IPSC","issuer_name_source":null,"issuer_url":"/issuer/0001543031","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.5314,"price_display":"1.53","price_state":"stated","total_value":7657.0,"total_display":"7,657.00","total_whole":"7,657","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":3073805,"accession":"0000950170-24-061294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-061294","line_url":"/filing/0000950170-24-061294#line-2","is_derivative":false,"issuer_cik":"0001543031","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543031","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":1.8899,"price_display":"1.89","price_state":"stated","total_value":4252.275,"total_display":"4,252.28","total_whole":"4,252","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-16","scope":"insider"},{"id":3073791,"accession":"0000950170-24-061294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-061294","line_url":"/filing/0000950170-24-061294#line-1","is_derivative":false,"issuer_cik":"0001543031","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543031","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2750.0,"shares_display":"2,750","price_per_share":1.885,"price_display":"1.88","price_state":"stated","total_value":5183.75,"total_display":"5,183.75","total_whole":"5,184","shares_owned_after":2750.0,"shares_owned_after_display":"2,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":7994385,"accession":"0001209191-23-004080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-004080","line_url":"/filing/0001209191-23-004080#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6923.0,"shares_display":"6,923","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":89999.0,"total_display":"89,999.00","total_whole":"89,999","shares_owned_after":398532.0,"shares_owned_after_display":"398,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":7994384,"accession":"0001209191-23-004080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004080","line_url":"/filing/0001209191-23-004080#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.4889,"price_display":"12.49","price_state":"stated","total_value":62444.5,"total_display":"62,444.50","total_whole":"62,445","shares_owned_after":405455.0,"shares_owned_after_display":"405,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6398970,"accession":"0001209191-22-048797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-048797","line_url":"/filing/0001209191-22-048797#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4397.0,"shares_display":"4,397","price_per_share":11.2851,"price_display":"11.29","price_state":"stated","total_value":49620.5847,"total_display":"49,620.58","total_whole":"49,621","shares_owned_after":335312.0,"shares_owned_after_display":"335,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6547920,"accession":"0001209191-22-045060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045060","line_url":"/filing/0001209191-22-045060#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5798.0,"shares_display":"5,798","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":69576.0,"total_display":"69,576.00","total_whole":"69,576","shares_owned_after":339709.0,"shares_owned_after_display":"339,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"},{"id":6456162,"accession":"0001209191-22-038365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038365","line_url":"/filing/0001209191-22-038365#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4396.0,"shares_display":"4,396","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":39564.0,"total_display":"39,564.00","total_whole":"39,564","shares_owned_after":345507.0,"shares_owned_after_display":"345,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":3209891,"accession":"0001209191-20-065059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065059","line_url":"/filing/0001209191-20-065059#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.0947,"price_display":"24.09","price_state":"stated","total_value":120473.5,"total_display":"120,473.50","total_whole":"120,474","shares_owned_after":244344.0,"shares_owned_after_display":"244,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider"},{"id":3117150,"accession":"0001209191-20-053728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-053728","line_url":"/filing/0001209191-20-053728#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.0198,"price_display":"14.02","price_state":"stated","total_value":70099.0,"total_display":"70,099.00","total_whole":"70,099","shares_owned_after":207179.0,"shares_owned_after_display":"207,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider"},{"id":2801925,"accession":"0001104659-20-081467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-081467","line_url":"/filing/0001104659-20-081467#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6872.0,"shares_display":"6,872","price_per_share":15.4723,"price_display":"15.47","price_state":"stated","total_value":106325.6456,"total_display":"106,325.65","total_whole":"106,326","shares_owned_after":207179.0,"shares_owned_after_display":"207,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-06","scope":"insider"},{"id":2576696,"accession":"0001209191-20-003091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-003091","line_url":"/filing/0001209191-20-003091#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":9.9301,"price_display":"9.93","price_state":"stated","total_value":148951.5,"total_display":"148,951.50","total_whole":"148,952","shares_owned_after":166969.0,"shares_owned_after_display":"166,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-10","scope":"insider"},{"id":6132982,"accession":"0001209191-18-018938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-018938","line_url":"/filing/0001209191-18-018938#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (SVP, Finance)","role_mark":"O","role_mark_label":"Officer (SVP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":131250.0,"total_display":"131,250.00","total_whole":"131,250","shares_owned_after":64332.0,"shares_owned_after_display":"64,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-03-12","scope":"insider"},{"id":6557061,"accession":"0001209191-18-016786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-016786","line_url":"/filing/0001209191-18-016786#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (SVP, Finance)","role_mark":"O","role_mark_label":"Officer (SVP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8149.0,"shares_display":"8,149","price_per_share":14.0553,"price_display":"14.06","price_state":"stated","total_value":114536.6397,"total_display":"114,536.64","total_whole":"114,537","shares_owned_after":64332.0,"shares_owned_after_display":"64,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider"},{"id":6816197,"accession":"0001209191-18-002051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-002051","line_url":"/filing/0001209191-18-002051#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (SVP, Finance)","role_mark":"O","role_mark_label":"Officer (SVP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.7154,"price_display":"14.72","price_state":"stated","total_value":117723.2,"total_display":"117,723.20","total_whole":"117,723","shares_owned_after":54676.0,"shares_owned_after_display":"54,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4872206,"accession":"0001209191-17-057053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057053","line_url":"/filing/0001209191-17-057053#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (SVP, Finance)","role_mark":"O","role_mark_label":"Officer (SVP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":14.2485,"price_display":"14.25","price_state":"stated","total_value":99739.5,"total_display":"99,739.50","total_whole":"99,740","shares_owned_after":54676.0,"shares_owned_after_display":"54,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-12","filed_date":"2017-10-16","scope":"insider"},{"id":2141178,"accession":"0001209191-16-149319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-149319","line_url":"/filing/0001209191-16-149319","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (SVP, Finance)","role_mark":"O","role_mark_label":"Officer (SVP, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8546.0,"shares_display":"8,546","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":68368.0,"total_display":"68,368.00","total_whole":"68,368","shares_owned_after":24189.0,"shares_owned_after_display":"24,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-10","scope":"insider","n_lines":2},{"id":8696775,"accession":"0001209191-15-074167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-074167","line_url":"/filing/0001209191-15-074167#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Vice President Finance)","role_mark":"O","role_mark_label":"Officer (Vice President Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":13.1343,"price_display":"13.13","price_state":"stated","total_value":147760.875,"total_display":"147,760.88","total_whole":"147,761","shares_owned_after":5688.0,"shares_owned_after_display":"5,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-05","scope":"insider"},{"id":8083754,"accession":"0001209191-15-070953","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-070953","line_url":"/filing/0001209191-15-070953#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Vice President Finance)","role_mark":"O","role_mark_label":"Officer (Vice President Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":18.08,"price_display":"18.08","price_state":"stated","total_value":45200.0,"total_display":"45,200.00","total_whole":"45,200","shares_owned_after":5688.0,"shares_owned_after_display":"5,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-14","filed_date":"2015-09-16","scope":"insider"},{"id":8495265,"accession":"0001209191-15-058122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-058122","line_url":"/filing/0001209191-15-058122#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (Vice President Finance)","role_mark":"O","role_mark_label":"Officer (Vice President Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President Finance","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":13.9808,"price_display":"13.98","price_state":"stated","total_value":36350.08,"total_display":"36,350.08","total_whole":"36,350","shares_owned_after":8188.0,"shares_owned_after_display":"8,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-01","scope":"insider"},{"id":8812105,"accession":"0001209191-15-042025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-042025","line_url":"/filing/0001209191-15-042025#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.8408,"price_display":"10.84","price_state":"stated","total_value":81306.0,"total_display":"81,306.00","total_whole":"81,306","shares_owned_after":8188.0,"shares_owned_after_display":"8,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-12","scope":"insider"},{"id":6532306,"accession":"0001209191-14-071258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-071258","line_url":"/filing/0001209191-14-071258#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":6532303,"accession":"0001209191-14-071258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-071258","line_url":"/filing/0001209191-14-071258#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":53500.0,"shares_owned_after_display":"53,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":6616514,"accession":"0001209191-14-062135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-062135","line_url":"/filing/0001209191-14-062135#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6812.0,"shares_display":"6,812","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":47684.0,"total_display":"47,684.00","total_whole":"47,684","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-06","scope":"insider"},{"id":6616511,"accession":"0001209191-14-062135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062135","line_url":"/filing/0001209191-14-062135#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6812.0,"shares_display":"6,812","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":47684.0,"total_display":"47,684.00","total_whole":"47,684","shares_owned_after":56812.0,"shares_owned_after_display":"56,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-06","scope":"insider"},{"id":6494179,"accession":"0001209191-14-060721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-060721","line_url":"/filing/0001209191-14-060721#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10738.0,"shares_display":"10,738","price_per_share":6.0966,"price_display":"6.10","price_state":"stated","total_value":65465.2908,"total_display":"65,465.29","total_whole":"65,465","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2014-10-01","scope":"insider"},{"id":6494177,"accession":"0001209191-14-060721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-060721","line_url":"/filing/0001209191-14-060721#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001543031","owner_name":"Quimi Daphne","owner_display_name":"Quimi Daphne","owner_url":"/insider/0001543031","role":"Officer (VP Finance and Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance and Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance and Controller","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10738.0,"shares_display":"10,738","price_per_share":6.0966,"price_display":"6.10","price_state":"stated","total_value":65465.2908,"total_display":"65,465.29","total_whole":"65,465","shares_owned_after":60738.0,"shares_owned_after_display":"60,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2014-10-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001850119","name":"Century Therapeutics, Inc.","url":"/issuer/0001850119","role":"Director","n_filings":1,"first_seen":"2024-09-16","last_seen":"2024-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001658551","name":"Amylyx Pharmaceuticals, Inc.","url":"/issuer/0001658551","role":"Director","n_filings":1,"first_seen":"2024-05-16","last_seen":"2024-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Officer (Chief Financial Officer)","n_filings":20,"first_seen":"2014-10-01","last_seen":"2023-01-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001543031","retrieved_at":"2026-08-26T03:53:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}